Regeneron Pharmaceuticals (REGN)
Net Receivables
$6.57B
Quarterly · Period ending: · USD
REGN Net Receivables
Latest reported$5.74Bperiod ending
Latest reported$5.74Bperiod ending
REGN FY Net Receivables ($200.00K → $5.74B)
Annual net receivables
High-resolution chart · PNG
REGN net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 5,741,100,000 | |
| 6,211,900,000 | |
| 5,667,300,000 | |
| 5,328,700,000 | |
| 6,036,500,000 | |
| 4,114,700,000 | |
| 2,785,600,000 | |
| 2,243,200,000 | |
| 1,974,340,000 | |
| 1,611,620,000 | |
| 1,467,793,000 | |
| 976,372,000 | |
| 954,967,000 | |
| 693,120,000 | |
| 103,035,000 | |
| 81,917,000 | |
| 65,568,000 | |
| 35,212,000 | |
| 18,320,000 | |
| 7,493,000 | |
| 36,521,000 | |
| 43,102,000 | |
| 15,529,000 | |
| 4,017,000 | |
| 2,975,000 | |
| 13,835,000 | |
| 600,000 | |
| 5,700,000 | |
| 6,600,000 | |
| 4,300,000 | |
| 2,700,000 | |
| 1,700,000 | |
| 1,700,000 | |
| 1,100,000 | |
| 1,400,000 | |
| 200,000 |